[{"Assets_0_Q2_USD":206610000.0,"CommonStockSharesOutstanding_0_Q2_shares":50309988.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":49292000.0,"NetIncomeLoss_2_Q2_USD":-16291000.0,"NetIncomeLoss_1_Q2_USD":-6874000.0,"StockholdersEquity_0_Q2_USD":28898000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":15022000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":24568000.0,"Ticker":"CCXI","CIK":"1340652","name":"CHEMOCENTRYX, INC.","OfficialName":"ChemoCentryx Inc. Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1508212562.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180809"}]